KOSDAQ · Healthcare · ₩184B
₩2,900-4.45%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 8.5% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“신약 출시 기반은 마련됐고, 이제 판매 확대를 확인할 차례예요.”
In the company's words · 2026 2분기 filing